Economia
Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market
2024 Global Biosimilars Report . The report provides a comprehensive analysis of global biosimilar trends, with a focus on competitive dynamics in the US and Europe. It highlights key players, their biosimilar-related licensing and M&A activities, and examines the legal and regulatory landscape influencing market growth.
Key insights from the report include:
“The global biosimilar market has matured significantly in recent years, with the US and EU leading this expansion,” said Alexandra Wollersheim, Partner at Alira Health. “Regulatory advances, such as the IRA and updated FDA guidance on biosimilar interchangeability, are driving this growth. With patent expirations and increasing biosimilar approvals, the market is on track to surpass $64 billion by 2028. This represents a significant shift in healthcare, delivering the benefits of biologics at reduced costs and expanding patient access while alleviating financial pressures on health systems.”
About Alira Health
Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and Medtech clients with a full spectrum of services across their entire solutions lifecycle. Learn more at AliraHealth.com .
Contact: John McLaughlin john.mclaughlin@alirahealth.com
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti